Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain

被引：27

作者：

Vazquez, Marta ^{[1
]}

Guevara, Natalia ^{[1
]}

Maldonado, Cecilia ^{[1
]}

Guido, Paulo Caceres ^{[2
]}

Schaiquevich, Paula ^{[3
,4
]}

机构：

[1] Univ Republica, Fac Quim, Dept Ciencias Farmaceut, Montevideo, Uruguay

[2] Hosp Pediat JP Garrahan, Unidad Farmacocinet Clin, Farm, Buenos Aires, DF, Argentina

[3] Hosp Pediat JP Garrahan, Med Precis, Buenos Aires, DF, Argentina

[4] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina

来源：

BIOMED RESEARCH INTERNATIONAL | 2020年 / 2020卷

关键词：

SEROTONIN REUPTAKE INHIBITORS; P-GLYCOPROTEIN INHIBITION; BLOOD-BRAIN-BARRIER; VALPROIC ACID; IN-VITRO; NEUROPATHIC PAIN; HUMAN LIVER; CANNABIDIOL; METABOLISM; VENLAFAXINE;

D O I：

10.1155/2020/3902740

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Choosing an appropriate treatment for chronic pain remains problematic, and despite the available medication for its treatment, still, many patients complain about pain and appeal to the use of cannabis derivatives for pain control. However, few data have been provided to clinicians about the pharmacokinetic drug-drug interactions of cannabinoids with other concomitant administered medications. Therefore, the aim of this brief review is to assess the interactions between cannabinoids and pain medication through drug transporters (ATP-binding cassette superfamily members) and/or metabolizing enzymes (cytochromes P450 and glucuronyl transferases).

引用

下载

页数：9

共 50 条

[21] Anticoagulant drug-drug interactions with cannabinoids: A systematic review
Smythe, Maureen A.
Wu, Wendy
Garwood, Candice L.
PHARMACOTHERAPY, 2023, 43 (12): : 1327 - 1338
[22] Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs
Molto, Jose
Rajoli, Rajith
Back, David
Valle, Marta
Miranda, Cristina
Owen, Andrew
Clotet, Bonaventura
Siccardi, Marco
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (03) : 805 - 811
[23] Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review
Ghasemiyeh, Parisa
Borhani-Haghighi, Afshin
Karimzadeh, Iman
Mohammadi-Samani, Soliman
Vazin, Afsaneh
Safari, Anahid
Qureshi, Adnan I.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 : 595 - 605
[24] Drug-drug interactions between clopidogrel and novel cardiovascular drugs
Pelliccia, Francesco
Rollini, Fabiana
Marazzi, Giuseppe
Greco, Cesare
Gaudio, Carlo
Angiolillo, Dominick J.
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 332 - 336
[25] The relationship between number of drugs and drug-drug interactions in the elderly
Johnell, Kristina
Klarin, Inga
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S17 - S18
[26] Drug-drug interactions between antiarrhythmic drugs in chick embryos
Yoshiyama, Y
Sugiyama, T
Kanke, M
Tsuchimoto, K
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (01) : 128 - 130
[27] Semantic Inference for Pharmacokinetic Drug-Drug Interactions
Moitra, Abha
Palla, Ravi
Tari, Luis
Krishnamoorthy, Mukkai
2014 IEEE INTERNATIONAL CONFERENCE ON SEMANTIC COMPUTING (ICSC), 2014, : 92 - 95
[28] Study and Prediction of Pharmacokinetic Drug-Drug Interactions
Hu, Zhe-Yi
CURRENT DRUG METABOLISM, 2014, 15 (08) : 759 - 760
[29] Pharmacokinetic and Pharmacodynamic Analyses of Drug-Drug Interactions between Iguratimod and Warfarin
Yamamoto, Tetsuya
Hasegawa, Kyoko
Onoda, Makoto
Tanaka, Keiichi
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (06): : 905 - 911
[30] Antihypertensive drugs in psychiatry Prescription behavior and potential drug-drug interactions
Endres, Katharina
Schiller, Ernst
Haen, Ekkehard
NERVENARZT, 2021, 92 (05): : 487 - 493

← 1 2 3 4 5 →